Gatifloxacin
Who holds supplier records for Gatifloxacin? 7 organisations hold a current record for Gatifloxacin: an active US FDA Type II Drug Master File. A further 5 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (5); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Gatifloxacin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/gatifloxacin
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
5 of the 5 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Gatifloxacin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 26452 · latest filing Sept 2012
- Apotex Pharmachem India Pvt. Ltd.IndiaActive DMF 20685 · latest filing Jul 2007
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 17012 · latest filing Dec 2003
- KYORIN PHARMACEUTICAL CO LTDActive DMF 13902, 15597 · latest filing Aug 2001
- Lupin LimitedIndia Company GMP cert on recordActive DMF 23552 · latest filing Apr 2010
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 17013 · latest filing Dec 2003
- STHREE CHEMICALS PRIVATE LTDActive DMF 40752 · latest filing Nov 2024
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (5)
Organisations whose Type II DMFs for Gatifloxacin are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- SIGNA SA DE CVInactive DMF 30999 · filed Dec 2016
- UQUIFA MEXICO SA DE CVInactive DMF 17822 · filed Nov 2004
- India · Inactive DMF 17110 · filed Jan 2004
- India · Inactive DMF 17092, 17002 · filed Jan 2004
- TEVA GROUPInactive DMF 16965 · filed Nov 2003
Overview
Gatifloxacin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL31).
Chemical identity
- IUPAC name
- 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
- Canonical SMILES
- CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
- InChIKey
- XUBOMFCQGDBHNK-UHFFFAOYSA-N
- Synonyms
- AM-1155, BMS-206584-01, BMS-20658401, Gatiflo, Gatifloxacin, Gatifloxacin anhydrous, Gatifloxacine, Gatifloxacin hydrate, Gatifloxacino, Gatifloxacin (sesquihydrate), Gatifloxacin sesquihydrate, NSC-758701
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Quinolone Antimicrobial
- Chemical structure
- Quinolones
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Gatifloxacin?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Gatifloxacin: APITORIA PHARMA PRIVATE LTD (India), Apotex Pharmachem India Pvt. Ltd. (India), Dr. Reddy's Laboratories Ltd. (India), KYORIN PHARMACEUTICAL CO LTD, Lupin Limited (India), MATRIX PHARMACORP PRIVATE LTD (India) and STHREE CHEMICALS PRIVATE LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Gatifloxacin Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 26452), Apotex Pharmachem India Pvt. Ltd. (DMF 20685), Dr. Reddy's Laboratories Ltd. (DMF 17012), KYORIN PHARMACEUTICAL CO LTD (DMF 13902, 15597), Lupin Limited (DMF 23552), MATRIX PHARMACORP PRIVATE LTD (DMF 17013) and STHREE CHEMICALS PRIVATE LTD (DMF 40752). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Gatifloxacin records mean?
5 organisations have only inactive Type II DMFs for Gatifloxacin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Gatifloxacin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Gatifloxacin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.